Spontaneous Regression of an Asymptomatic Meningioma Associated With Discontinuation of Progesterone Agonist Administration -Case Report-
Authors:
Open Access
- 1 January 2008
- journal article
- case report
- Published by Japan Neurosurgical Society in Neurologia medico-chirurgica
- Vol. 48 (5) , 227-230
Abstract
An 80-year-old male visited the hospital as an outpatient with a head injury sustained in a traffic accident. Brain computed tomography incidentally revealed a left frontal lobe tumor measuring 5 cm in a diameter. The patient had a history of taking chlormadinone acetate (a progesterone agonist) prescribed several years previously as treatment for benign prostatic hypertrophy. The tumor was seen as an isointense lesion on T1-weighted magnetic resonance (MR) images with enhancement by gadolinium, and as a heterogeneously hyperintense mass on T2-weighted MR images. The tentative diagnosis was left frontal meningioma attached to the sphenoid ridge or sphenoid plane. The patient was managed conservatively because of his advanced age and no symptoms or progression were observed during a 9-month follow-up period. The medication for benign prostatic hypertrophy was changed from chlormadinone acetate to naftopidil (an alpha-2-blocker) about 9 months after his first presentation. The patient presented again 2 years later complaining of dizziness. Computed tomography and MR imaging performed at this time revealed remarkable regression of the tumor. The signal intensity change with regression of the tumor on T2-weighted images was observed as a hypointense lesion. Thus, we wish to emphasize that treatment of meningiomas, especially those diagnosed incidentally, must be based on a thorough consideration of any history of hormonal therapy with prostate disease.Keywords
This publication has 21 references indexed in Scilit:
- Long-Term Administration of Mifepristone (RU486): Clinical Tolerance During Extended Treatment of MeningiomaCancer Investigation, 2006
- Multiple meningiomas arising during long-term therapy with the progesterone agonist megesterol acetateJournal of Neurosurgery, 2004
- Hormone receptors in non-malignant meningiomas correlate with apoptosis, cell proliferation and recurrence-free survivalHistopathology, 2003
- Histologically Classified Venous Angiomas of the Brain: A Controversy.Neurologia medico-chirurgica, 2003
- Brain TumorsNew England Journal of Medicine, 2001
- Incidence and clinical features of asymptomatic meningiomasJournal of Neurosurgery, 2000
- Progesterone and estrogen receptors in meningiomas: prognostic considerationsJournal of Neurosurgery, 1997
- Immunohistochemical Detection of Female Sex Hormone Receptors in MeningiomasNeurosurgery, 1993
- Treatment of unresectable meningiomas with the antiprogesterone agent mifepristoneJournal of Neurosurgery, 1991
- Hormonotherapy of meningiomas with medroxyprogesterone acetateSurgical Neurology, 1988